The latest version of RCOG’s guidance was made available on 11 January 2022, previously having been updated in December 2021.
v14.2 (December 2021) Minor updates included:
• Quick reference summary: replaced by flowchart
• Section 2: Minor updates of vaccination safety data
• Section 6: Clarification of Ronapreve dose to 2.4g, restoration of dexamethasone dose to 12mg intramuscular x2 (24 hours apart), advice not to use Molupiravir outside a trial settings and on neonatal BCG after maternal administration of Tocolizumab.
• Section 7: Update of postnatal neonatal guidance in line with BAPM
• Addition of appendix IV: Example of a telephone triage tool for symptomatic women with suspected or confirmed COVID-19
Also included is a Treatment of COVID-19 in pregnant patients one page sheet
Version 14.3 January 2022 minor updates include:
• Section 2: Minor updates on omicron vaccine efficacy.
• Section 6: Recognition that monoclonal antibody advice is
changing rapidly, with external links for clarification. Clarification
of recommended steroid preparations, with addition of
methylprednisolone if preferred.
• Section 7: Aligning with BAPM isolation advice.
View the updated guidance here